GlassScriptPhysician profile
Thomas Warren Roblee
NPI 1265023378
$3,116.11
in general payments reported to CMS, 2019-2025
11 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 92% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $500 · 2021: $13.51 · 2022: $184 · 2023: $563 · 2024: $650 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.17 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightforce Orthodontics, INC. | $1,196.59 | 2022-2025 | |
| Kls-Martin L.P. | $562.22 | 2023-2024 | |
| Ormco Corporation | $522.99 | 2020-2022 | |
| Envista Holdings Corporation | $377.50 | 2024-2025 | Spark |
| Nobel Biocare USA | $150.00 | 2023 | Nobelactive |
| Dental Monitoring Sas | $103.85 | 2025 | |
| American Orthodontics Corporation | $88.63 | 2022-2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| Align Technology, INC. | $37.20 | 2021-2025 | Invisalign |
| Peter Brasseler Holdings, LLC | $33.63 | 2024 | |
| World Class Technology Corporation | $26.81 | 2024 | Pitts21, Pitts21 Pro |
| Carestream Dental, LLC | $16.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Roblee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.